Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers

Neoadjuvant therapy (NAT) has been used increasingly in patients with locally advanced or early-stage breast cancer. However, the accurate evaluation and prediction of response to NAT remain the great challenge. Biomarkers could prove useful to identify responders or nonresponders, or even to distin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wenyong, Yang, Ming, Yang, Hongli, Zhou, Fangbin, Shen, Weixi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188192/
https://www.ncbi.nlm.nih.gov/pubmed/30349367
http://dx.doi.org/10.2147/CMAR.S174435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188192/
https://www.ncbi.nlm.nih.gov/pubmed/30349367
http://dx.doi.org/10.2147/CMAR.S174435

Ejemplares similares